Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.

Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA.

Intern Med J. 2014 Jul;44(7):676-82. doi: 10.1111/imj.12453.

PMID:
24750233
2.

Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.

Song A, Eo W, Lee S.

World J Gastroenterol. 2015 Nov 21;21(43):12410-20. doi: 10.3748/wjg.v21.i43.12410.

3.

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2011 Nov;47(17):2633-41. doi: 10.1016/j.ejca.2011.03.028. Epub 2011 Jul 1.

PMID:
21724383
4.

The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.

Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Matsushima M.

Ann Surg Oncol. 2015 Mar;22(3):803-10. doi: 10.1245/s10434-014-4048-0. Epub 2014 Sep 5.

PMID:
25190127
5.

Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.

Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH.

Med Oncol. 2012 Dec;29(5):3092-100. doi: 10.1007/s12032-012-0226-8. Epub 2012 Apr 5.

PMID:
22476808
6.

Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review.

Ahmad J, Grimes N, Farid S, Morris-Stiff G.

Hepatobiliary Pancreat Dis Int. 2014 Oct;13(5):474-81. Review.

PMID:
25308357
7.

A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.

Xu XL, Yu HQ, Hu W, Song Q, Mao WM.

PLoS One. 2015 Sep 21;10(9):e0138657. doi: 10.1371/journal.pone.0138657. eCollection 2015.

8.

Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.

Inoue D, Ozaka M, Matsuyama M, Yamada I, Takano K, Saiura A, Ishii H.

Jpn J Clin Oncol. 2015 Jan;45(1):61-6. doi: 10.1093/jjco/hyu159. Epub 2014 Oct 23.

PMID:
25341546
9.

Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.

Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, Horgan PG, McMillan DC.

Br J Cancer. 2013 Jul 9;109(1):24-8. doi: 10.1038/bjc.2013.330. Epub 2013 Jun 25.

10.

Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.

Linton A, Pond G, Clarke S, Vardy J, Galsky M, Sonpavde G.

Clin Genitourin Cancer. 2013 Dec;11(4):423-30. doi: 10.1016/j.clgc.2013.04.020. Epub 2013 Jun 28.

PMID:
23816526
11.

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.

Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C, Jin Y, Zhou YX, Wang DS, He MM, Bai L, Wang F, Luo HY, Li YH, Xu RH.

BMC Cancer. 2015 May 2;15:350. doi: 10.1186/s12885-015-1379-6.

12.

Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.

Laird BJ, Kaasa S, McMillan DC, Fallon MT, Hjermstad MJ, Fayers P, Klepstad P.

Clin Cancer Res. 2013 Oct 1;19(19):5456-64. doi: 10.1158/1078-0432.CCR-13-1066. Epub 2013 Aug 12.

13.

Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.

Qi Q, Geng Y, Sun M, Wang P, Chen Z.

Pancreatology. 2015 Mar-Apr;15(2):145-50. doi: 10.1016/j.pan.2014.12.004. Epub 2015 Jan 10.

PMID:
25641673
14.

Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.

Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, Kim YR.

Oncology. 2012;83(5):292-9. doi: 10.1159/000342376. Epub 2012 Sep 5.

PMID:
22964877
15.

Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.

Geng Y, Qi Q, Sun M, Chen H, Wang P, Chen Z.

Eur J Surg Oncol. 2015 Nov;41(11):1508-14. doi: 10.1016/j.ejso.2015.07.022. Epub 2015 Aug 28.

PMID:
26343824
16.

A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.

Li JP, Chen SL, Liu XM, He X, Xing S, Liu YJ, Lin YH, Liu WL.

Int J Mol Sci. 2016 Nov 15;17(11). pii: E1900.

17.

The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study.

Tan CS, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ.

Support Care Cancer. 2015 Feb;23(2):385-91. doi: 10.1007/s00520-014-2385-y. Epub 2014 Aug 13.

PMID:
25112562
18.

Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.

Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI.

Am J Surg. 2010 Aug;200(2):197-203. doi: 10.1016/j.amjsurg.2009.08.041. Epub 2010 Feb 1.

PMID:
20122680
19.

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.

Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Medicine (Baltimore). 2016 May;95(18):e3582. doi: 10.1097/MD.0000000000003582.

20.

Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.

Xiao Y, Ren YK, Cheng HJ, Wang L, Luo SX.

Int J Clin Exp Pathol. 2015 May 1;8(5):5273-81. eCollection 2015.

Supplemental Content

Support Center